Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
NCT00362674
·
clinicaltrials.gov ↗
COMPLETED
Status
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Sponsor
Bukwang Pharmaceutical